Simple exercises may boost nerve repair in diabetic neuropathy
NCT ID NCT07675720
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study compares two exercise programs—combined aerobic and resistance training versus seated soleus push-ups—against standard care in people with type 2 diabetes and diabetic peripheral neuropathy. Researchers will measure blood markers of nerve repair (BDNF, NGF, S100B) and assess changes in symptoms, balance, and quality of life over 8 weeks. The goal is to identify which exercise approach best supports nerve health and function.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- exercise (concurrent training or soleus push-ups)
- What this could lead to
- If effective, these exercises could offer a simple, drug-free way to support nerve repair and reduce symptoms of diabetic neuropathy.
- What could go wrong
- This is a small, early-stage trial measuring biological markers, not clinical outcomes. Results may not translate to meaningful symptom improvement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 99 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 40-65 years * Diagnosed Type 2 Diabetes Mellitus (T2DM) Confirmed diagnosis of T2DM for at least 5 years. * Confirmed Diabetic Peripheral Neuropathy (DPN) Diagnosis is based on clinical evaluation and scoring tools such as: * Michigan Neuropathy Screening Instrument (MNSI) Cut-off value of ≥4 for Part A (History)(104) Cut-off value of ≥2 from Part B (Examination)(105) * Vibration Pressure Threshold (≥25 Volts)(106) * HbA1c between 6.5% and 9.0% Reflecting moderate glycemic control, patients with extremely poor control were excluded for safety. * Stable medication regimen No changes in antidiabetic, antihypertensive, or neuropathy medications in the past 3 months. * Sedentary or low physical activity level Based on standard questionnaires (International Physical Activity Questionnaire - IPAQ), not currently engaged in structured exercise programs. * Ability to walk independently To ensure safety during aerobic or resistance exercise (for Group A). * Able to understand and follow instructions * Consent to participate and comply with study protocol * Written informed consent, obtained before randomization Exclusion Criteria: * History of recent cardiovascular events Includes myocardial infarction, stroke, or any cardiac intervention within the past 6 months. * Uncontrolled hypertension Blood pressure ≥160/100 mmHg at rest. * Severe musculoskeletal disorders or physical disability Including joint deformities, fractures, or amputation that limit the ability to perform exercise. * Severe diabetic foot ulcers or active lower limb infection Increases risk during lower limb activity or exercise. * End-stage renal disease (CKD stage 4 or higher) Associated systemic complications may confound study outcomes or affect safety. * Severe retinopathy or proliferative diabetic eye disease Exercise may pose risks such as retinal hemorrhage. * Current Smoker, tobacco or alcohol consumer. That may affect the blood biomarkers. * Cognitive impairment or psychiatric disorders That may affect understanding, compliance, or safety during exercise. * Participation in a structured exercise program within the last 3 months To avoid training-induced bias and ensure a sedentary baseline. * Chronic inflammatory or autoimmune conditions Conditions like rheumatoid arthritis or lupus may alter neurotrophic biomarkers. * Use of medications affecting neurogenesis or metabolism Such as corticosteroids, antipsychotics, or immunosuppressants. * Diagnosed sleep disorder * That may affect the outcomes of the intervention. * Pregnancy or lactation Due to altered physiology and ethical concerns.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetic peripheral neuropathy type 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Pakistan Railways General Hospital and Mediplex Healthcare Center
Rawalpindi, 46210, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.